(R)-(3-Aminopyrrolidin-1-yl)(4-fluorophenyl)methanone, 95.0%, 1g

4-(4-Hydroxyphenyl)-3,6-dihydropyridine-1(2H)-carboxamide, 98%, 100mg

Indeno[1,2,3-cd]pyrene, 98%, 100mg

(2R,3R)-3-((tert-Butoxycarbonyl)amino)-2-hydroxy-3-(4-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 250mg

Ethyl 3-Amino-4,4,4-trifluorocrotonate>97.0%(GC)5g

4-Chloro-2,6-difluorobenzaldehyde, 98.0%, 25g

(S)-(+)-O-Acetyl-L-mandelic acid, 95.0%, 10g

1-(4-Chloropyridin-3-yl)ethanone hydrochloride, 95.0%, 1g

L-Methionin, min. 99 %, für die Biochemie, 250 g, kunststoffverpackung.

3-[(4-Chlorophenyl)thio]-1-(3,5-dichlorophenyl)pyrrolidine-2,5-dione, 95.0%, 10g

1,4,6,7-tetrahydroimidazo[4,5-e][1,4]diazepine-5,8-dione, 90.0%, 1g

Nirogacestat, 98.76%, 5mg

(S)-2-Amino-3-(4-hydroxyphenyl)-2-methylpropanoic acid, 95.0%, 5g